Cenk Akbostanci
Overview
Explore the profile of Cenk Akbostanci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gemici Y, Ekici C, Batum M, Akbostanci C, Koc A, Mavioglu H
Rheumatol Adv Pract
. 2024 Jul;
8(3):rkae083.
PMID: 39055541
Objectives: We describe the clinical pictures of an index case with dystonia and his family resulting from and genetic variations based on previously published data and discuss the mechanisms that...
2.
Vural A, Simsir G, Tekgul S, Kocoglu C, Akcimen F, Kartal E, et al.
Mov Disord
. 2021 Feb;
36(7):1676-1688.
PMID: 33624863
Background: The genetic and epidemiological features of hereditary ataxias have been reported in several populations; however, Turkey is still unexplored. Due to high consanguinity, recessive ataxias are more common in...
3.
Eryilmaz I, Erer S, Zarifoglu M, Egeli U, Karakus E, Yurdacan B, et al.
Clin Neurol Neurosurg
. 2020 Oct;
199:106257.
PMID: 33039854
In the present study, we focused on investigating the contribution of functional dopamine D2 and D3 receptor variants to motor and/or non-motor symptoms of early onset Parkinson's disease (EOPD). Three...
4.
Pamukcu H, Gerede Uludag D, Tak B, Sorgun M, Efe T, Acibuca A, et al.
Anatol J Cardiol
. 2018 Dec;
21(1):54.
PMID: 30587711
No abstract available.
5.
Pamukcu H, Gerede Uludag D, Tak B, Sorgun M, Efe T, Acibuca A, et al.
Anatol J Cardiol
. 2018 Oct;
20(4):213-219.
PMID: 30297579
Objective: Parkinson's disease (PD) is a neurological disorder, and ergot dopamine agonists (DAs) are no longer usually preferred in the treatment due to the increased risk of valvular heart disease....
6.
Eryilmaz I, Cecener G, Erer S, Egeli U, Tunca B, Zarifoglu M, et al.
Neurol Res
. 2017 Aug;
39(11):965-972.
PMID: 28830306
Background and aim The effect of epigenetic modifications in the genes related to Parkinson's disease (PD) is still unclear. In the present study, we investigated methylation status of SNCA and...
7.
Akkoc Y, Gok H, Karapolat H, Ersoz M, Sungur U, Koklu K, et al.
Neurourol Urodyn
. 2017 Feb;
36(7):1903-1909.
PMID: 28139847
Aims: To investigate the reliability and validity of the Turkish version of the Danish Prostate Symptom Score (Dan-PSS) questionnaire in patients with Parkinson's disease (PD) and to compare the burden...
8.
Gulsuner H, Gulsuner S, Mercan F, Onat O, Walsh T, Shahin H, et al.
Proc Natl Acad Sci U S A
. 2015 Apr;
112(18):E2269.
PMID: 25825780
No abstract available.
9.
Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease
Gulsuner H, Gulsuner S, Mercan F, Onat O, Walsh T, Shahin H, et al.
Proc Natl Acad Sci U S A
. 2014 Nov;
111(51):18285-90.
PMID: 25422467
Essential tremor is one of the most frequent movement disorders of humans and can be associated with substantial disability. Some but not all persons with essential tremor develop signs of...
10.
Savas A, Bozkurt M, Akbostanci C
Acta Neurochir Suppl
. 2013 May;
117:35-41.
PMID: 23652654
Background: Several methods are used for targeting of the subthalamic nucleus (STN) for the surgical treatment of Parkinson's disease (PD). The goal of this study is to determine the most...